CX

Cheng Xie

GC Guangdong Raynovent Biotech Co.: 5 patents #6 of 39Top 20%
MD Medshine Discovery: 4 patents #17 of 162Top 15%
CC Chia Tai Tianqing Pharmaceutical Group Co.: 2 patents #101 of 370Top 30%
Overall (All Time): #436,747 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12319692 Anti-influenza virus pyrimidine derivatives Jian Xiong, Chaofeng Long, Jingjing Wang, Xiaoxin Chen, Kevin X. Chen +4 more 2025-06-03
12030897 Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof Kevin X. Chen, Fen JIANG, Xinde Chen, Li Zhang, Zhaoguo Chen +4 more 2024-07-09
11725009 Anti-influenza virus pyrimidine derivative Jian Xiong, Chaofeng Long, Jingjing Wang, Xiaoxin Chen, Kevin X. Chen +4 more 2023-08-15
11649239 Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1) Kevin X. Chen, Yanxin YU, Xinde Chen, Li Zhang, Zhaoguo Chen 2023-05-16
11535613 Crystal form and salt form of pyridoimidazole compound and preparation method therefor Jian Xiong, Xiaoxin Chen, Jingjing Wang, Zhuowei Liu, Kevin X. Chen +5 more 2022-12-27
11466036 Borate of azetidine derivative Jian Xiong, Xiongbin XU, Kevin X. Chen, Jian Li, Shuhui CHEN +3 more 2022-10-11
11136319 Anti-influenza virus pyrimidine derivative Jian Xiong, Chaofeng Long, Jingjing Wang, Xiaoxin Chen, Kevin X. Chen +4 more 2021-10-05
11117899 [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor Kevin X. Chen, Yanxin YU, Xinde Chen, Li Zhang, Zhaoguo Chen +5 more 2021-09-14
11014943 Azetidine derivative Jian Xiong, Kevin X. Chen, Xiongbin XU, Xuejin Zhang, Zhen Gong +6 more 2021-05-25
10654808 Tyrosine kinase inhibitor and pharmaceutical composition comprising same Chaofeng Long, Zhengxia Chen, Xiaoxin Chen, Yang Zhang, Zhuowei Liu +7 more 2020-05-19
10519133 Vinyl compounds as FGFR and VEGFR inhibitors Shuhui CHEN, Zhengxia Chen, Meibi Dai, Peng Li, Yang Zhang +6 more 2019-12-31